9 research outputs found

    Chemical Tumor-Targeting of Nanoparticles Based on Metabolic Glycoengineering and Click Chemistry

    No full text
    Tumor-targeting strategies for nanoparticles have been predominantly based on optimization of physical properties or conjugation with biological ligands. However, their tumor-targeting abilities remain limited and insufficient. Furthermore, traditional biological binding molecules have intrinsic limitations originating from the limited amount of cellular receptors and the heterogeneity of tumor cells. Our two-step <i>in vivo</i> tumor-targeting strategy for nanoparticles is based on metabolic glycoengineering and click chemistry. First, an intravenous injection of precursor-loaded glycol chitosan nanoparticles generates azide groups on tumor tissue specifically by the enhanced permeation and retention (EPR) effect followed by metabolic glycoengineering. These ‘receptor-like’ chemical groups then enhance the tumor-targeting ability of drug-containing nanoparticles by copper-free click chemistry <i>in vivo</i> during a second intravenous injection. The advantage of this protocol over traditional binding molecules is that there are significantly more binding molecules on the surface of most tumor cells regardless of cell type. The subsequent enhanced tumor-targeting ability can significantly enhance the cancer therapeutic efficacy in animal studies

    Precise Targeting of Liver Tumor Using Glycol Chitosan Nanoparticles: Mechanisms, Key Factors, and Their Implications

    No full text
    Herein, we elucidated the mechanisms and key factors for the tumor-targeting ability of nanoparticles that presented high targeting efficiency for liver tumor. We used several different nanoparticles with sizes of 200–300 nm, including liposome nanoparticles (LNPs), polystyrene nanoparticles (PNPs) and glycol chitosan-5β-cholanic acid nanoparticles (CNPs). Their sizes are suitable for the enhanced permeation and retention (EPR) effect in literature. Different <i>in vitro</i> characteristics, such as the particle structure, stability, and bioinertness, were carefully analyzed with and without serum proteins. Also, pH-dependent tumor cell uptakes of nanoparticles were studied using fluorescence microscopy. Importantly, CNPs had sufficient stability and bioinertness to maintain their nanoparticle structure in the bloodstream, and they also presented prolonged circulation time in the body (blood circulation half-life <i>T</i><sub>1/2</sub> = about 12.2 h), compared to the control nanoparticles. Finally, employing liver tumor bearing mice, we also observed that CNPs had excellent liver tumor targeting ability <i>in vivo</i>, while LNPs and PNPs demonstrated lower tumor-targeting efficiency due to the nonspecific accumulation in normal liver tissue. Liver tumor models were produced by laparotomy and direct injection of HT29 tumor cells into the left lobe of the liver of athymic nude mice. This study provides valuable information concerning the key factors for the tumor-targeting ability of nanoparticles such as stability, bioinertness, and rapid cellular uptake at targeted tumor tissues

    Forest plot of hazard ratios for the associations between post- liver transplantation sarcopenia and survival.

    No full text
    <p>BMI, body mass index; MELD, model for end-stage liver disease; ESRD, end-stage renal disease; HD, hemodialysis; DM, diabetes mellitus; HCC, hepatocellular carcinoma; LT, liver transplantation; CDLT, cadaveric donor liver transplantation; LDLT, living donor liver transplantation; GRWR, graft-to-recipient body weight ratio; CSA, cyclosporine; CI, confidence interval</p

    Baseline characteristics of the liver transplantation (LT) recipients.

    No full text
    <p>Continuous variables are presented as means ± standard deviations and were analyzed using Student’s t-tests. Categorical variables are presented as numbers and percentages and were compared using the χ<sup>2</sup> test with Yates' continuity correction.</p><p>BMI, body mass index;</p><p>MELD, model for end-stage liver disease;</p><p>DM, diabetes mellitus;</p><p>HBV, hepatitis B virus,</p><p>HCC, hepatocellular carcinoma;</p><p>LT, liver transplantation;</p><p>GRWR, graft-to-recipient body weight ratio;</p><p>CSA, cyclosporine;</p><p>MMF, mycopenolate mofetil</p><p><sup>a</sup>Based on a comparison of post-LT non-sarcopenia patients and post-LT sarcopenia patients</p><p><sup>b</sup>Postoperative immunosuppressive treatment</p><p><sup>c</sup>Change in calcineurin inhibitors during the postoperative period</p><p>Baseline characteristics of the liver transplantation (LT) recipients.</p

    Facile Method To Radiolabel Glycol Chitosan Nanoparticles with <sup>64</sup>Cu via Copper-Free Click Chemistry for MicroPET Imaging

    No full text
    An efficient and straightforward method for radiolabeling nanoparticles is urgently needed to understand the <i>in vivo</i> biodistribution of nanoparticles. Herein, we investigated a facile and highly efficient strategy to prepare radiolabeled glycol chitosan nanoparticles with <sup>64</sup>Cu via a strain-promoted azide–alkyne cycloaddition strategy, which is often referred to as click chemistry. First, the azide (N<sub>3</sub>) group, which allows for the preparation of radiolabeled nanoparticles by copper-free click chemistry, was incorporated to glycol chitosan nanoparticles (CNPs). Second, the strained cyclooctyne derivative, dibenzyl cyclooctyne (DBCO) conjugated with a 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA) chelator, was synthesized for preparing the preradiolabeled alkyne complex with <sup>64</sup>Cu radionuclide. Following incubation with the <sup>64</sup>Cu-radiolabeled DBCO complex (DBCO-PEG<sub>4</sub>-Lys-DOTA-<sup>64</sup>Cu with high specific activity, 18.5 GBq/μmol), the azide-functionalized CNPs were radiolabeled successfully with <sup>64</sup>Cu, with a high radiolabeling efficiency and a high radiolabeling yield (>98%). Importantly, the radiolabeling of CNPs by copper-free click chemistry was accomplished within 30 min, with great efficiency in aqueous conditions. In addition, we found that the <sup>64</sup>Cu-radiolabeled CNPs (<sup>64</sup>Cu-CNPs) did not show any significant effect on the physicochemical properties, such as size, zeta potential, or spherical morphology. After <sup>64</sup>Cu-CNPs were intravenously administered to tumor-bearing mice, the real-time, <i>in vivo</i> biodistribution and tumor-targeting ability of <sup>64</sup>Cu-CNPs were quantitatively evaluated by microPET images of tumor-bearing mice. These results demonstrate the benefit of copper-free click chemistry as a facile, preradiolabeling approach to conveniently radiolabel nanoparticles for evaluating the real-time <i>in vivo</i> biodistribution of nanoparticles
    corecore